| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Jon Berg CEO | XFRA Exchange | SE0005731833 ISIN |
| DE Country | 20 Employees | - Last Dividend | - Last Split | - IPO Date |
BrainCool AB (publ) is a pioneering medical device company operating out of Lund, Sweden. Founded in 2010, the company is dedicated to advancing the healthcare sector by focusing on the development, marketing, and sale of innovative medical cooling systems. BrainCool operates at both domestic and international levels, continuously working on enhancing its product lineup to cater to a wide array of medical situations requiring rapid cooling treatments. It addresses critical health issues such as stroke, sudden cardiac arrest, oral mucositis, and migraines. Through its commitment to improving patient care, BrainCool AB aims to position itself as a leader in the medical cooling treatment industry, providing solutions that facilitate a continuum of care from emergency settings to recovery and rehabilitation phases.
This system represents a cornerstone in BrainCool's product line, offering efficient and rapid cooling treatment options in emergency settings. It is specifically designed to ensure the continuum of care for patients suffering from conditions such as stroke or sudden cardiac arrest. The BrainCool System makes it easier for healthcare providers to initiate treatment promptly, potentially reducing the severity of these conditions.
Targeted towards rapid medical cooling in both hospital and pre-hospital settings, the RhinoChill System is designed for versatility and ease of use. Its portability makes it ideally suited for use in ambulances or emergency care, where the immediate lowering of the patient's body temperature can be crucial for their recovery and survival.
Understanding the significant impact of oral mucositis on patients undergoing certain cancer treatments, the Cooral System was developed to mitigate this challenging side effect. By providing a straightforward and effective cooling treatment directly to the oral cavity, the Cooral System aims to reduce the incidence and severity of oral mucositis, thereby improving the patient's quality of life during treatment.
With an emphasis on user-friendliness, the IQool System boasts an intuitive interface, enlightening graphics, and an automatic feedback loop. These features enable clinicians to focus more on patient care rather than equipment operation. The system is designed for managing therapeutic hypothermia, assisting in the regulation of the patient's body temperature with precision and ease.